1. WESSENDORF, J., H. RETTENMAIER AND F. LINGENS: Degradation of Lawson by Pseudomonas putida L2. Biol. Chem. Hoppe-Seyler 366 (1985), 945-51

2. WESSENDORF, J.: Einfluß von Anzucht- und Bodenbedingungen auf das Überleben eines Pseudomonas fluorescens-Stammes im Boden. Dissertation, Universität Hohenheim (1988)
3. WESSENDORF, J. AND F. LINGENS: Effect of culture and soil conditions on survival of Pseudomonas fluorescens R1 in soil. Appl. Microbiol. Biotechnol. 31 (1989), 97-104
4. GARFINKEL, S., D. S. HAINES, S. BROWN, J. WESSENDORF, D. H. GILLESPIE AND T. MACIAG: Interleukin-1 mediates an alterna-tive pathway for the antiprolifera-tive action of poly(I:C) on human endothelial cells. J. Biol. Chem. 267 (1992), 24375-8
5. WESSENDORF, J. H. M., S. GARFINKEL, X. ZHAN, S. BROWN AND T. MACIAG: Identification of a nuclear translocation sequence within the structure of the human interleukin-1 precursor. J. Biol. Chem. 268 (1993), 22100-4
6. GARFINKEL, S., S. BROWN, J. H. M. WESSENDORF AND T. MACIAG: Post-transcriptional regulation of IL-1a in different strains of young and senescent human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. USA 91 (1993), 1559-63
7. MACIAG, T., X. ZHAN, S. FRIEDMAN, S. GARFINKEL, I. PRUDOVSKY, A. JACKSON, J. WESSENDORF, X. HU, S. GAMBLE, J. SHI, S. BROWN, F. TARANTINI AND A. ZIMRIN: Novel mechanisms of Fibroblast Growth Factor-1 function. Recent Prog. Horm. Res. 49 (1994), 105-23
8. RISTIMÄKI, A., S. GARFINKEL, J. WESSENDORF, T. MACIAG AND T. HLA: Induction of cyclooxygenase-2 by interleukin-1. Evidence for post-transcriptional regulation. J. Biol. Chem. 269 (1994), 11769-75
9. GARFINKEL, S., J.H.M. WESSENDORF, X. HU, AND T. MACIAG: The human diploid fibroblast senescence pathway is independent of interleukin-1a mRNA levels and tyrosine phosphorylation of FGFR-1 substrates. Biochim. Biophys. Acta Mol. Cell Res. (1996), 109-19
10. MAGERSTAEDT, R., S. KRAFT, I. STROBEL, M. JÜRGENS, D. HANAU, J. WESSENDORF AND T. BIEBER. Induction of Fc epsilon RI alpha mRNA and protein synthesis by interleukin 4 in CD 34+ cells-derived CD1a+ dendritic cells. Adv. Exp. Med. Biol. 417 (1997), 353-5
11. KRAFT, S., J.H.M. WESSENDORF, D. HANAU AND T.BIEBER. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J. Immunology 161 (1998), 1000-6
12. WESSENDORF, J. AND T. BIEBER. Cell purification using magnetic beads. In: Teillaud, J.L., C. Sautes, and O. Cochet (Ed.), Immunological techniques for biology and medicine: A practical guide to common laboratory procedures, Wiley-Verlag, NY, USA (1998)
13. GEIGER, E., R. MAGERSTAEDT, J.H.M. WESSENDORF, S. KRAFT, D. HANAU AND T. BIEBER. Interleukin-4 induces the intracellular expression of the alpha-chain of the high affinity receptor for IgE in in vitro dendritic cells. J. Allergy Clin. Immunol. 105 (2000), 150-6
14. KATOH, N., S. KRAFT, J.H.M. WESSENDORF AND T. BIEBER. The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes. J. Clin. Invest. 105 (2000), 183-90
15. VON BUBNOFF, D., H. DE LA SALLE, J. WESSENDORF, S. KOCH, D. HANAU AND T. BIEBER. Antigen-presenting cells and tolerance induction. Allergy 57 (2002), 2-8
16. KRAFT, S., J.H. WESSENDORF, J. HABERSTOK, N. NOVAK, A. WOLLENBERG, T. BIEBER. Enhanced expression and activity of protein-tyrosine kinases establishes a functional signaling pathway only in Fc epsilon RI high Langerhans cells from atopic individuals. J. Invest. Dermatol. 119 (2002), 804-11

Zurück zur Seite von Dr. J. Weßendorf